Dr S Eswara Reddy rejoins CDSCO as Joint drug controller
The Delhi High Court in September had granted bail to Reddy who was then in judicial custody.
New Delhi: Dr S Eswara Reddy has rejoined the Central Drugs Standard Control Organisation (CDSCO) as joint drug controller after his suspension over bribery allegation was revoked on December 26.
Reddy was suspended following his arrest by the Central Bureau of Investigation (CBI) in June, along with an associate vice-president of Biocon Limited, on bribery charges in connection with waiving of Phase-3 clinical trials for an insulin injection.
The Delhi High Court in September had granted bail to Reddy who was then in judicial custody.
Read also: Biocon Bribery Case: Delhi HC grants bail to Joint Drug Controller, 2 others
In October, Reddy had written to the Health Ministry seeking justice and revocation of his suspension orders, saying he was implicated in a "totally false case so as to deprive my promotion, tarnishing my image and damaging my reputation as an honest and sincere officer".
He has now rejoined in his earlier position in the apex drug regulatory body.
Reddy had earlier served as the drug controller general of India from February 2018 to August 2019. He did his PhD from J.N.T.U, Hyderabad. At CDSCO, Dr. Reddy headed various internal divisions like import & registration, medical devices, biologicals, new drugs, and others.
Read also: CBI apprehends persons over bribery case at DCGI office, role of Joint Drugs Controller under scanner
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd